CAMK2G and Alzheimer disease: Importantly, at 12–16 weeks of age, Tg(CaMKII-hA2AR) animals present a 5–8-fold increase of hippocampal A2AR immunoreactivity [30], which is of the same magnitude as the increase found in our human aged and AD samples (Fig. 1b), and equivalent to that of aged rats [22].